Axogen, Inc. — Director's Dealing 2020

Jun 12, 2020

SEC Form 4/A — Form 4/A

Issuer: Axogen, Inc. (AXGN)
CIK: 0000805928
Period of Report: 2020-06-01

Reporting Person: Levine Alan M (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-06-01	Stock Option (right to purchase)	$9.72	A	12605	Acquired	2030-06-01	Common Stock (12605)	Direct
2020-06-01	Restricted Stock Units	$	A	6173	Acquired		Common Stock (6173)	Direct

Footnotes

F1: Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $120,000 valuation as of the grant date and vests on June 1, 2021, one year from the anniversary of the grant date. One-half of the annual equity grant value is in the form of non-qualified stock options and one-half of the annual equity grant value is in the form of restricted stock units.

F2: Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock.

F3: The original Form 4 filed on June 3, 2020, is a duplicate filing. The updated beneficial holdings are being submitted in this Form 4/A.